London, United Kingdom

Upamali Perera

This inventor holds 1 USPTO granted patent. Top assignees: King's College London, Massachusetts Institute of Technology. Active years: 2019.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Upamali Perera: Innovator in Cancer Treatment

Introduction

Upamali Perera is a notable inventor based in London, GB. He has made significant contributions to the field of cancer research, particularly in the identification and treatment of invasive and metastatic breast cancers. His innovative approach focuses on the molecular mechanisms underlying cancer cell invasion.

Latest Patents

Upamali Perera holds a patent for "Methods for identifying and treating invasive/metastatic breast cancers." This patent addresses the critical issue of cancer invasion, which is a hallmark of metastasis. The invention describes compositions and methods for assessing and treating subjects with metastatic cancer, specifically through the determination of Lamellipodin protein or gene expression levels. He has 1 patent to his name.

Career Highlights

Throughout his career, Upamali has worked with prestigious institutions such as the Massachusetts Institute of Technology and King's College London. His work has been instrumental in advancing the understanding of cancer biology and developing new therapeutic strategies.

Collaborations

Upamali has collaborated with esteemed colleagues, including Frank B Gertler and Guillaume Carmona. These partnerships have enriched his research and contributed to the advancement of cancer treatment methodologies.

Conclusion

Upamali Perera's innovative work in cancer research exemplifies the impact of scientific inquiry on medical advancements. His contributions are paving the way for improved treatment options for patients facing metastatic breast cancer.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…